European Lithium's Twin Regulatory Stalemates Keep Merger Discount at 20% as Cash Condition Met

European Lithium meets A$330M cash condition for Critical Metals merger, but ASX probe and Greenland permit delay keep stock at 20% discount; dual CEO role adds investor caution.

European Lithium has cleared one of the key financial hurdles for its planned tie-up with Nasdaq-listed Critical Metals Corp., but two separate regulatory logjams are keeping the deal's value discount firmly in place. The company's cash balance now stands at roughly A$356 million after selling 2.5 million Critical Metals shares for around A$45 million — well above the A$330 million minimum required to close the transaction. Yet the stock continues to trade at a nearly 20% discount to the implied offer price on European exchanges, reflecting a market that is far from convinced the merger will proceed smoothly.

That skepticism stems from a pair of unresolved issues. In Australia, the ASX has suspended trading in European Lithium shares since May 18 while it investigates whether the company breached its disclosure obligations. The regulator wants to know why media reports about the merger talks surfaced before the company formally notified the market. European Lithium argues that the discussions only became material at the end of April when a non-binding letter of intent was signed. The suspension, originally slated to lift on May 20, has been extended indefinitely.

On the operational side, the cornerstone of the deal — the Tanbreez rare earths project in Greenland — is stuck waiting for a mining permit. Critical Metals holds a 92.5% stake in the asset, which contains strategically important terbium and dysprosium, two elements vital for electric motors and defence systems. Greenland's government has yet to approve the necessary licence, meaning the planned extraction of a 150-tonne sample in June cannot go ahead. The delay comes at a particularly awkward time: China's export restrictions on these rare earths are suspended only until November 2026, narrowing the window for Western supply chain alternatives.

The valuation gap is easy to calculate. Under the binding merger agreement announced on May 18, European Lithium shareholders will receive 0.035 Critical Metals shares for each share they hold. That works out to an implied value of A$0.58 per share. On European exchanges, the stock recently closed at around A$0.475 (€0.30), a 20% shortfall. The market is effectively pricing in the regulatory overhang in Australia, the permitting paralysis in Greenland, and the structural conflict of interest that complicates the deal's governance.

Tony Sage sits in both chairs — as chairman of European Lithium and CEO of Critical Metals. To manage the conflict, European Lithium established an independent committee that is recommending shareholders accept the offer, provided no superior proposal emerges and an independent expert deems the terms fair. That recommendation carries weight, but the dual role inevitably fuels investor caution.

Meanwhile, the company has been quietly adjusting its portfolio. It took part in a capital raising by Helix Resources, which placed 534.6 million shares as part of a 1.34 billion share issue. The proceeds will fund Helix's Weerianna gold-lithium project in Western Australia, giving European Lithium commodity exposure without the operational burden. The stake can be sold if needed to keep cash above the A$330 million threshold. Separately, European Lithium trimmed its voting rights in CuFe Limited from 17.85% to 16.73%.

The merger is structured as an Australian scheme of arrangement, requiring approval from a majority of voting shareholders plus at least 75% of the votes cast. The timeline has already slipped: shareholder documents are now slated for July or August, with meetings in August or September, followed by court and regulatory approvals. A completion in the first half of 2026 is off the table.

Until the ASX lifts its suspension and Greenland issues the permit, the 20% discount on European Lithium's stock is likely to persist. The company has the cash cushion to meet its obligations, but it cannot buy its way out of the twin delays that are keeping the deal in a state of limbo.